tradingkey.logo

CapsoVision Inc

CV
5.070USD
+0.110+2.22%
收盘 02/09, 16:00美东报价延迟15分钟
234.96M总市值
亏损市盈率 TTM

CapsoVision Inc

5.070
+0.110+2.22%

关于 CapsoVision Inc 公司

CapsoVision, Inc. is a global medical device innovator which specializes in diagnostic imaging of the gastrointestinal system. Its flagship product, CapsoCam Plus, is a small bowel capsule endoscope that uses a novel 360 panoramic lateral view to overcome the limitations of end-facing cameras and provide a more comprehensive imaging solution, while its wire-free design provides unparalleled comfort and convenience to patients. Its CapsoCloud is a next generation, cloud-based software application that makes clinical data management convenient and secure. Its capsule collection kit is a sanitary, single-use kit provided to patients for the collection, storage and transportation of the CapsoCam Plus capsule.

CapsoVision Inc简介

公司代码CV
公司名称CapsoVision Inc
上市日期Jul 02, 2025
CEOWang (Kang-Huai)
员工数量90
证券类型Ordinary Share
年结日Jul 02
公司地址18805 Cox Avenue
城市SARATOGA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编95070
电话14086241488
网址https://www.capsovision.com/
公司代码CV
上市日期Jul 02, 2025
CEOWang (Kang-Huai)

CapsoVision Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Kang-Huai (Johnny) Wang
Mr. Kang-Huai (Johnny) Wang
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.10M
+1104004.00%
Mr. Chen Lung Tsai
Mr. Chen Lung Tsai
Independent Chairman of the Board
Independent Chairman of the Board
118.36K
+2887.00%
Mr. Wen-Herng Henry King
Mr. Wen-Herng Henry King
Independent Director Nominee
Independent Director Nominee
44.31K
+2887.00%
Ms. Hui Ying (Patty) Kuo
Ms. Hui Ying (Patty) Kuo
Independent Director
Independent Director
23.60K
+2887.00%
Ms. Julia S. Gouw
Ms. Julia S. Gouw
Independent Director Nominee
Independent Director Nominee
2.89K
+2887.00%
Mr. Douglas Atkinson
Mr. Douglas Atkinson
Head of Global Sales
Head of Global Sales
--
--
Dr. Joanne Imperial, M.D.
Dr. Joanne Imperial, M.D.
Independent Director Nominee
Independent Director Nominee
--
--
Mr. Min-Liang Chen
Mr. Min-Liang Chen
Director
Director
--
--
Mr. Eliyahou Harari
Mr. Eliyahou Harari
Director
Director
--
--
Mr. Howard Lee
Mr. Howard Lee
Director
Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Kang-Huai (Johnny) Wang
Mr. Kang-Huai (Johnny) Wang
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
1.10M
+1104004.00%
Mr. Chen Lung Tsai
Mr. Chen Lung Tsai
Independent Chairman of the Board
Independent Chairman of the Board
118.36K
+2887.00%
Mr. Wen-Herng Henry King
Mr. Wen-Herng Henry King
Independent Director Nominee
Independent Director Nominee
44.31K
+2887.00%
Ms. Hui Ying (Patty) Kuo
Ms. Hui Ying (Patty) Kuo
Independent Director
Independent Director
23.60K
+2887.00%
Ms. Julia S. Gouw
Ms. Julia S. Gouw
Independent Director Nominee
Independent Director Nominee
2.89K
+2887.00%
Mr. Douglas Atkinson
Mr. Douglas Atkinson
Head of Global Sales
Head of Global Sales
--
--

收入明细

单位: USD更新时间: 1月6日 周二
单位: USD更新时间: 1月6日 周二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q2
FY2024Q1
FY2023
业务USD
名称
营收
占比
Products (capsules and capsule reading devices)
3.30M
93.39%
Services (cloud-based video delivery and reading services)
234.00K
6.61%
地区USD
名称
营收
占比
United States
2.75M
77.70%
Outside United States
789.00K
22.30%
业务
地区
业务USD
名称
营收
占比
Products (capsules and capsule reading devices)
3.30M
93.39%
Services (cloud-based video delivery and reading services)
234.00K
6.61%

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Harari Eliyahou Et Al
9.19%
Ching-Hang (Shen)
8.52%
Kioxia Corporation
7.36%
CID Greater China Venture Capital Fund III, L.P.
6.67%
Shih-Chang (Stephen Wu)
5.04%
其他
63.22%
持股股东
持股股东
占比
Harari Eliyahou Et Al
9.19%
Ching-Hang (Shen)
8.52%
Kioxia Corporation
7.36%
CID Greater China Venture Capital Fund III, L.P.
6.67%
Shih-Chang (Stephen Wu)
5.04%
其他
63.22%
股东类型
持股股东
占比
Individual Investor
17.61%
Corporation
14.03%
Other Insider Investor
9.19%
Investment Advisor
0.51%
Investment Advisor/Hedge Fund
0.42%
Hedge Fund
0.06%
Research Firm
0.02%
Pension Fund
0.02%
Bank and Trust
0.01%
其他
58.14%

机构持股

更新时间: 1月21日 周三
更新时间: 1月21日 周三
报告期
机构数
持股数
持股占比
持股变动
2026Q4
37
408.58K
0.06%
--
2025Q4
39
481.38K
1.03%
+382.86K
2025Q3
11
196.14K
0.42%
+171.24K

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Harari Eliyahou Et Al
4.31M
9.19%
+4.31M
--
Jul 02, 2025
Ching-Hang (Shen)
3.99M
8.52%
+81.00K
+2.07%
Oct 01, 2025
Kioxia Corporation
3.45M
7.36%
+3.45M
--
Jul 02, 2025
CID Greater China Venture Capital Fund III, L.P.
3.13M
6.67%
-1.00
-0.00%
Sep 30, 2025
Shih-Chang (Stephen Wu)
2.36M
5.04%
+2.36M
--
Jul 02, 2025
Wang (Kang-Huai)
1.10M
2.36%
+1.10M
--
Jul 03, 2025
Harari (Michele)
576.80K
1.23%
+2.89K
+0.50%
Dec 31, 2025
The Vanguard Group, Inc.
69.58K
0.15%
+69.58K
--
Sep 30, 2025
Tsai (Chen Lung)
118.34K
0.25%
+2.89K
+2.50%
Dec 31, 2025
Geode Capital Management, L.L.C.
115.03K
0.25%
+90.13K
+361.98%
Sep 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.01%
Global X Russell 2000 ETF
0%
ProShares UltraPro Russell2000
0%
Proshares Ultra Russell 2000
0%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 Growth ETF
0%
iShares Micro-Cap ETF
占比0.01%
Global X Russell 2000 ETF
占比0%
ProShares UltraPro Russell2000
占比0%
Proshares Ultra Russell 2000
占比0%
ProShares Hedge Replication ETF
占比0%
iShares Russell 2000 Growth ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
KeyAI